Cannara Biotech (CNSX:LOVE – Get Free Report) Director Donald John Olds acquired 30,000 shares of the firm’s stock in a transaction on Thursday, May 9th. The stock was purchased at an average cost of $0.78 per share, for a total transaction of $23,250.00.
Cannara Biotech Stock Performance
Cannara Biotech Company Profile
Cannara Biotech Inc is a vertically integrated cannabis company building the largest indoor cannabis cultivation facility in Quebec, a modern and secure 625,000 square foot facility. Leveraging Quebec’s low electricity costs, Cannara will produce high-grade indoor cannabis, specializing in derivative products and brands.
Read More
- Five stocks we like better than Cannara Biotech
- Canadian Penny Stocks: Can They Make You Rich?
- Bounce Alert: 3 Large Caps With RSIs Too Good To Ignore
- Buy P&G Now, Before It Sets A New All-Time High
- Unity Software’s Mixed Q1, But Long-Term Outlook Remains Positive
- Stock Analyst Ratings and Canadian Analyst Ratings
- JFrog Stock Gets Punished for Solid Results: Buy the Dip
Receive News & Ratings for Cannara Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannara Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
